Integrated Core Strategies (US) LLC 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 4:00 pm Sale |
2024-12-31 | 13G | Verve Therapeutics, Inc. VERV |
Integrated Core Strategies (US) LLC | 3,919,131 4.600% |
-1,446,090 (-26.95%) |
Filing |
| 2024-09-09 4:36 pm Purchase |
2024-08-30 | 13G | Verve Therapeutics, Inc. VERV |
Integrated Core Strategies (US) LLC | 5,365,221 6.300% |
1,064,216 (+24.74%) |
Filing |
| 2024-06-27 4:42 pm Purchase |
2024-06-21 | 13G | Verve Therapeutics, Inc. VERV |
Integrated Core Strategies (US) LLC | 4,301,005 5.100% |
4,301,005 (New Position) |
Filing |